Pharmaceutical

MIXT IV Spa: Bringing Modern IV Therapy to Los Alamitos & Surrounding Cities

MIXT IV Spa, a Modern Health and Wellness Destination, is Excited to Announce Its Opening in Los Alamitos, Proudly Serving…

3 months ago

MIXT IV Spa: Bringing Modern IV Therapy to Los Alamitos & Surrounding Cities

MIXT IV Spa, a Modern Health and Wellness Destination, is Excited to Announce Its Opening in Los Alamitos, Proudly Serving…

3 months ago

Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ’s About Increased Guidance to $80M Pro Forma Revenue, Sportstech and TRNR’s $50M Digital Asset Treasury

AUSTIN, TX / ACCESS Newswire / September 11, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of…

3 months ago

Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ’s About Increased Guidance to $80M Pro Forma Revenue, Sportstech and TRNR’s $50M Digital Asset Treasury

AUSTIN, TX / ACCESS Newswire / September 11, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of…

3 months ago

MentalHealth.com Responds to WHO’s Call: Scaling Global Solutions for Mental Health

One Billion People Living With Mental Health Conditions ATLANTA, GA / ACCESS Newswire / September 11, 2025 / The World…

3 months ago

MentalHealth.com Responds to WHO’s Call: Scaling Global Solutions for Mental Health

One Billion People Living With Mental Health Conditions ATLANTA, GA / ACCESS Newswire / September 11, 2025 / The World…

3 months ago

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development,…

3 months ago

Athira Pharma Announces Reverse Stock Split

BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira” or “Company”) (NASDAQ: ATHA), a clinical stage biopharmaceutical…

3 months ago

Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome

NPI-001 shows more than 50% reduction in photoreceptor loss caused by RP associated with USH over two years NPI-001 was…

3 months ago

RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, 2025…

3 months ago